0000899243-22-017890.txt : 20220512
0000899243-22-017890.hdr.sgml : 20220512
20220512211859
ACCESSION NUMBER: 0000899243-22-017890
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220510
FILED AS OF DATE: 20220512
DATE AS OF CHANGE: 20220512
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Carson Seana
CENTRAL INDEX KEY: 0001923756
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14956
FILM NUMBER: 22919912
MAIL ADDRESS:
STREET 1: 400 SOMERSET CORPORATE BLVD
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Bausch Health Companies Inc.
CENTRAL INDEX KEY: 0000885590
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2150 ST. ELZEAR BLVD. WEST
STREET 2: LAVAL
CITY: QUEBEC
STATE: A8
ZIP: H7L 4A8
BUSINESS PHONE: 514-744-6792
MAIL ADDRESS:
STREET 1: 2150 ST. ELZEAR BLVD. WEST
STREET 2: LAVAL
CITY: QUEBEC
STATE: A8
ZIP: H7L 4A8
FORMER COMPANY:
FORMER CONFORMED NAME: Valeant Pharmaceuticals International, Inc.
DATE OF NAME CHANGE: 20100928
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL Corp
DATE OF NAME CHANGE: 20100416
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL
DATE OF NAME CHANGE: 19960522
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-05-10
0
0000885590
Bausch Health Companies Inc.
BHC
0001923756
Carson Seana
400 SOMERSET CORPORATE BOULEVARD
BRIDGEWATER
08807
0
1
0
0
EVP, General Counsel
Common Shares, No Par Value
2022-05-10
4
M
0
2752
A
71322
D
Common Shares, No Par Value
2022-05-10
4
M
0
4715
A
76037
D
Restricted Share Units
2022-05-10
4
A
0
2752
A
2022-05-10
Common Shares, No Par Value
2752
0
D
Restricted Share Units
2022-05-10
4
M
0
2752
9.40
D
2022-05-10
Common Shares, No Par Value
0
0
D
Restricted Share Units
2022-05-10
4
A
0
4715
A
2022-05-10
Common Shares, No Par Value
4715
0
D
Restricted Share Units
2022-05-10
4
M
0
4715
9.40
D
2022-05-10
Common Shares, No Par Value
0
0
D
Reflects an award of performance-based Restricted Share Units ("PSUs"), previously granted to the reporting person on February 26, 2020, that was earned upon the certification of performance metrics applicable to such PSUs. The earned PSUs will vest on February 26, 2023, subject to the reporting person's continuous service.
Reflects an award of PSUs, previously granted to the reporting person on March 3, 2021, that was earned upon the certification of performance metrics applicable to such PSUs. The earned PSUs will vest on March 3, 2023, subject to the reporting person's continuous service.
Each PSU converts into common shares, no par value, of the Issuer on a one-for-one basis.
/s/ Brianna M. Cetrulo, attorney-in-fact
2022-05-12